NASDAQ:PTGX
Protagonist Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.protagonist-inc.comipo date
Aug 11, 2016
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary...Show More
Earnings
Earnings Release in 6 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus